XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Total Equity Attributable to Class A and Class B Common Stockholders
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2021     176,460,407        
Beginning balance at Dec. 31, 2021 $ (1,827) $ (44,326) $ 18 $ 3,219,081 $ (350) $ (3,263,075) $ 42,499
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock awards (in shares)     964,937        
ESPP purchase (in shares)     420,689        
ESPP purchase 5,981 5,981   5,981      
Exercise of stock options (in shares)     149,662        
Exercise of stock options 980 980   980      
Stock-based compensation 25,586 25,586   25,586      
Distributions and payments to noncontrolling interests (2,876) (500)   (500)     (2,376)
Foreign currency translation adjustment (153) (153)     (153)    
Net loss [1] (82,447) (78,359)       (78,359) (4,088)
Ending balance (in shares) at Mar. 31, 2022     177,995,695        
Ending balance at Mar. 31, 2022 (54,756) (90,791) $ 18 3,251,128 (503) (3,341,434) 36,035
Beginning balance (in shares) at Dec. 31, 2022     205,664,690        
Beginning balance at Dec. 31, 2022 378,816 340,777 $ 20 3,906,491 (1,251) (3,564,483) 38,039
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock awards (in shares)     2,104,904        
ESPP purchase (in shares)     449,525        
ESPP purchase 7,756 7,756   7,756      
Exercise of stock options (in shares)     114,526        
Exercise of stock options 769 769   769      
Stock-based compensation 29,294 29,294   29,294      
Derecognition of the pre-modification forward contract fair value (Note 15) 76,242 76,242   76,242      
Equity component of redeemable convertible preferred stock, Series B (Note 15) 16,145 16,145   16,145      
Foreign currency translation adjustment (271) (101)     (101)   (170)
Net loss (74,917) (71,567)       (71,567) (3,350)
Ending balance (in shares) at Mar. 31, 2023     208,333,645        
Ending balance at Mar. 31, 2023 $ 433,834 $ 399,315 $ 20 $ 4,036,697 $ (1,352) $ (3,636,050) $ 34,519
[1] Excludes $300 attributable to redeemable noncontrolling interest.Note: Beginning redeemable noncontrolling interest of $300 - Net loss attributable to redeemable noncontrolling interest of $300 = ending redeemable noncontrolling interest of Nil.